No single vitamin has strong enough evidence to be recommended as a standalone treatment for Peyronie’s disease, and the most widely discussed option, vitamin E, is explicitly advised against by the American Urological Association. That said, research into antioxidants and related supplements has produced some genuinely interesting findings, particularly for coenzyme Q10 and certain multi-agent combinations. The disconnect between popular advice and clinical guidelines makes this a topic worth understanding carefully before spending money on supplements.
Why Antioxidants Keep Coming Up
Peyronie’s disease is a fibrotic condition where scar-like plaque forms inside the penis, leading to curvature, shortening, pain, and sometimes erectile problems. It affects roughly 3 to 9 percent of adult men, though the real number may be higher since many cases go unreported.1Oxford Academic (Sexual Medicine Reviews). Review of Management Options for Active-Phase Peyronie’s Disease The condition tends to have an active phase, where the plaque is still forming and pain is common, followed by a stable phase where the curvature has set but pain has usually resolved.
The reason vitamins and antioxidants get attention in this context comes down to oxidative stress. Researchers have found that oxidative stress plays a key role in the inflammatory processes that drive plaque formation in Peyronie’s disease.2Europe PMC. Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants In theory, if you can reduce the oxidative damage happening in penile tissue, you might slow plaque buildup or reduce its severity. That reasoning is sound enough to justify research, but the jump from “oxidative stress is involved” to “taking vitamin X will fix it” is much bigger than most supplement marketing suggests.
Vitamin E and the Gap Between Popularity and Evidence
Vitamin E is by far the most commonly mentioned supplement for Peyronie’s disease. It has been used in this context since the 1940s, and you will still find it recommended on many health websites and even by some clinicians. The logic seems straightforward: vitamin E is a fat-soluble antioxidant, penile tissue is vulnerable to oxidative damage, so vitamin E should help protect it.
The problem is that controlled studies have not backed this up. When researchers have compared vitamin E to placebo in properly designed trials, the results have been underwhelming. The American Urological Association’s clinical guideline on Peyronie’s disease is blunt about this. It states that clinicians should not offer oral therapy with vitamin E, noting there is “no convincing evidence for the efficacy” of this treatment. That recommendation carries a Grade B evidence rating, meaning it is based on a reasonable body of research, not just expert opinion.3PubMed Central. Peyronie’s Disease: AUA Guideline
The same guideline also advises against omega-3 fatty acids and the combination of vitamin E with L-carnitine, both of which have been studied and found lacking.3PubMed Central. Peyronie’s Disease: AUA Guideline This is worth knowing because the vitamin E plus L-carnitine combination is still sold and promoted for this purpose.
There is an additional safety consideration. Vitamin E at high doses can worsen blood clotting problems, particularly in people who are deficient in vitamin K or who take anticoagulant medications.4Free Radical Biology and Medicine. Tolerance and safety of vitamin E: A toxicological position report If you are taking blood thinners and considering vitamin E supplementation for any reason, that interaction is something to discuss with your doctor.
The Vitamin D Puzzle
Vitamin D has attracted attention because of its known roles in immune regulation and tissue repair. A small study comparing men with Peyronie’s disease to healthy controls found that every patient in the Peyronie’s group was deficient in vitamin D, compared to only about 44 percent of the control group. The average blood level of 25-hydroxyvitamin D was meaningfully lower in the Peyronie’s group, roughly 42 nmol/L versus 65 nmol/L in the controls.5The Journal of Sexual Medicine. Vitamin D and Peyronie’s Disease
That sounds like a clear signal, but a separate study found the opposite: men with Peyronie’s disease actually had significantly higher vitamin D levels than controls, averaging about 33 ng/mL compared to roughly 19 ng/mL in healthy men.6PubMed. Is high levels of vitamin D a new risk factor for Peyronie’s disease? The two findings directly contradict each other, and neither study was large. This is a good example of why a single study, even a well-designed one, should not drive treatment decisions. Until larger research clarifies the relationship, there is no reliable basis for recommending vitamin D specifically for Peyronie’s disease. Correcting a genuine vitamin D deficiency is sensible for general health, but that is different from taking extra vitamin D to treat penile plaque.
Coenzyme Q10 Stands Out
Among individual supplements studied for Peyronie’s disease, coenzyme Q10 has the strongest evidence from a properly controlled trial. A randomized, double-blind, placebo-controlled study of 186 men with early chronic Peyronie’s disease compared 300 mg of CoQ10 daily to placebo over 24 weeks. The men taking CoQ10 saw reductions in plaque size and penile curvature, while the placebo group experienced slight increases in both. Erectile function scores, pain ratings, and treatment satisfaction all improved in the CoQ10 group as well.7PubMed. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized study
A network meta-analysis that compared multiple treatments for Peyronie’s disease across published studies also found CoQ10 at 300 mg to be among the therapies that reached statistical significance for effectiveness.8PubMed Central. Medical Treatment for Peyronie’s Disease: Systematic Review and Network Bayesian Meta-Analysis That is encouraging, but one important caveat: the CoQ10 evidence still rests heavily on a single randomized trial. In medicine, a finding usually needs to be replicated by independent research groups before it becomes a strong recommendation. CoQ10 for Peyronie’s disease has not yet crossed that threshold.
CoQ10 is generally well tolerated at these doses and does not carry the bleeding-risk concerns associated with high-dose vitamin E. If you are looking for a supplement with the best individual evidence in this space, CoQ10 is the most defensible choice, but go in with realistic expectations. “Statistically significant improvement” in a trial does not always translate to a dramatic change you would notice day-to-day.
Combination Approaches and Why They Complicate the Picture
Some of the more promising results in Peyronie’s disease research come not from single vitamins or supplements but from combination protocols that pair multiple agents together. One controlled study used a regimen that included pentoxifylline (a prescription drug that improves blood flow), vitamin E at 600 mg daily, propolis, blueberry extract, and topical diclofenac gel. One group also received pentoxifylline injections directly into the plaque. After six months, the group receiving the full protocol saw an average plaque volume reduction of nearly 47 percent and curvature reduction of about 10 degrees. The group without the injections still saw plaque shrink by about 25 percent and curvature drop by nearly 5 degrees. Both groups had similar rates of pain resolution, around 67 percent.9PubMed Central. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study
These are genuinely impressive numbers, but the study design makes it impossible to tell which ingredients drove the improvement. Was the vitamin E contributing something useful in this context even though it fails as a solo therapy? Was the blueberry extract carrying any weight, or was pentoxifylline doing most of the work? When everything is bundled together, you cannot isolate the contribution of any single component. The network meta-analysis mentioned earlier also flagged the combination of vitamin E at 300 mg with propionyl-L-carnitine as statistically significant, even though neither agent on its own has strong support.8PubMed Central. Medical Treatment for Peyronie’s Disease: Systematic Review and Network Bayesian Meta-Analysis
This is where the evidence gets genuinely tricky. A vitamin or supplement that fails as a single treatment might still have value as part of a broader protocol, but we do not have the studies needed to confirm that. It also means that the AUA’s recommendation against vitamin E as a standalone therapy may not apply to combination approaches, but those combinations typically include prescription medications and are not something you can replicate with an over-the-counter supplement stack.
What About POTABA?
Potassium para-aminobenzoate, sold under the brand name POTABA, is sometimes grouped with vitamin supplements even though it is technically a B-complex derivative available by prescription in some countries. A prospective, placebo-controlled trial of 103 men found that the treatment group had a 74 percent response rate compared to 50 percent on placebo. Average plaque size dropped from 259 mm² to 142 mm² in the treated group, while it initially grew in the placebo group before partially shrinking.10PubMed Central. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebo-controlled, randomized study
POTABA has a notable downside: the dosing regimen is demanding, typically requiring multiple large tablets spread across the day, and gastrointestinal side effects are common enough that many men stop taking it before completing a full course. It is also not widely available everywhere. Still, its evidence base is stronger than that of most supplements marketed for Peyronie’s disease, and it is worth knowing about if you are exploring medical options with your urologist.
How Antioxidant Therapy Fits Into the Bigger Treatment Picture
Current conservative treatment for Peyronie’s disease includes oral medications, penile injections, and physical therapies like traction devices and shockwave therapy.2Europe PMC. Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants Vitamins and supplements sit firmly in the “oral” category and are most commonly tried during the active phase, when the disease is still progressing and plaque is not yet fully hardened. The theory is that antioxidants may slow or limit the inflammatory cascade that feeds plaque growth during this window.
Researchers who advocate for antioxidant treatment argue that the positive results seen in some studies validate the approach, and that the doses used in trials were adequate without crossing into territory where antioxidants might interfere with normal cellular signaling.2Europe PMC. Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants That last point matters because antioxidants are not always benign at high doses. The body uses reactive oxygen species for legitimate purposes, including wound healing and immune defense. Flooding the system with antioxidants at megadose levels can theoretically interfere with those processes. The therapeutic window, taking enough to reduce harmful oxidative stress without disrupting beneficial signaling, is not well mapped for Peyronie’s disease.
For men whose disease has stabilized and who are left with significant curvature, supplements are unlikely to reverse established plaque. At that point, treatment options shift toward intralesional injections, traction therapy, or surgery depending on the severity and how much the curvature affects function or quality of life.
The Dupuytren Connection
Peyronie’s disease does not exist in isolation. It belongs to a family of fibrotic conditions that share underlying mechanisms. The most common relative is Dupuytren’s disease, which causes similar fibrous tissue to form in the palm of the hand, eventually pulling fingers into a bent position. Among a group of 730 men with Dupuytren’s disease, roughly 8 to 9 percent also had Peyronie’s disease, a rate considerably higher than the general population.11Plastic & Reconstructive Surgery. Prevalence of Peyronie and Ledderhose Diseases in a Series of 730 Patients with Dupuytren Disease Ledderhose disease, a fibrotic condition of the sole of the foot, was even more common in that group, affecting over 20 percent.
This clustering is relevant because it suggests a shared genetic or biochemical predisposition to abnormal fibrosis. If your body tends to lay down excess scar tissue in one location, it may do so in others. Interestingly, the same oxidative-stress and inflammatory pathways implicated in Peyronie’s disease are thought to contribute to Dupuytren’s and Ledderhose as well. Whether antioxidant therapy might help across all three conditions is an open and largely unexplored question. If you have Dupuytren’s disease and notice penile changes, or vice versa, the overlap is something to raise with your doctor, as it may affect the approach to monitoring and treatment for both conditions.
Practical Decisions If You Are Considering Supplements
If you search online for vitamins to help with Peyronie’s disease, you will find no shortage of supplement companies happy to sell you blends of vitamin E, L-carnitine, CoQ10, and various herbal extracts marketed specifically for this condition. Here is what the evidence actually supports when it comes to making decisions about your own treatment:
- Vitamin E alone: Not recommended by the AUA. Decades of use have not produced convincing evidence of benefit.
- CoQ10: The best-supported individual supplement, based on one solid randomized trial at 300 mg daily. Reasonable to try, but results may be modest.
- Vitamin D: Conflicting data. Correcting a deficiency is good general practice, but there is no basis for taking extra vitamin D to treat Peyronie’s specifically.
- Combination protocols: Some show real promise, but the effective ones typically include prescription drugs alongside supplements. A supplement-only version of these regimens has not been tested.
- POTABA: Has decent evidence but is a prescription product, not a typical supplement. Compliance is difficult due to the pill burden.
Timing matters too. Most supplement trials in Peyronie’s disease were conducted during the active or early chronic phase. If your disease has been stable for a year or more and your curvature is set, starting a supplement regimen is unlikely to reverse the existing plaque. That does not mean it is pointless, since some men with stable disease still experience flares, but realistic expectations are important. No vitamin or supplement has been shown to “cure” Peyronie’s disease, and any product claiming otherwise is overselling the science.
One more thing worth noting: Peyronie’s disease has a surprisingly high placebo response rate in clinical trials. In some studies, men taking sugar pills reported pain reduction, improved satisfaction, and even modest changes in curvature. This does not mean the condition is imaginary; rather, it reflects the natural course of the disease, which often improves somewhat on its own, particularly regarding pain. When evaluating whether a supplement is “working” for you, keep in mind that improvement you notice over a few months might have happened regardless.